Press Release: DMC Appoints Kenny Erdoes as COO
- Tuesday, 17 May 2022
17 May 2022 – DMC Biotechnologies has appointed Kenny Erdoes as Chief Operating Officer (COO), effective immediately. Kenny has more than 20 years of experience in process engineering, project development and manufacturing operations.
Kenny Erdoes is a chemical engineer with a broad range of experience in building and operating manufacturing facilities for different company sizes and varying product markets. He has a consistent track record of successful execution across a diversity of countries and cultures.
Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC, said, “Kenny Erdoes is a seasoned professional and a welcome addition to the DMC team as we bring our first wave of products to the market following our latest fundraise. Kenny’s calm, confident leadership will be a great asset as we take DMC to the next phase.”
Kenny Erdoes, Chief Operating Officer of DMC, said, “I am thrilled to be joining DMC Biotechnologies at this time, as their technology and renewable platform are a giant leap forward for producing chemicals predictably and sustainably. I look forward to working with a very talented team to ensure the long-term success of DMC.”
DMC’s technology platform addresses the key barriers that have plagued the biotech industry for decades including standardization, robustness, and predictability across scale. Addressing these challenges translates to a dramatic reduction in the time to market and the investment needed to bring products to commercialization.